We founded the Swiss Ventures Group because the wealth of experience we have accumulated over the years is meant to be shared. Check out our news and find extensive background information on investments, startups and the world of VC.
SNAQ, a Serpentine Ventures portfolio company, received a US patent for its technology that converts food images into precise nutritional data. This milestone secures their innovative platform for 20 years.
BOYDSense, a Serpentine Ventures portfolio company, was selected by the European Innovation Council (EISMEA) to pitch at the HealthTech Investor Day in Paris. This recognition highlights their innovation in diabetes technology.
LOXO, a Serpentine Ventures portfolio company, has launched LOXO GmbH in Munich, marking its entry into the German market. This expansion supports LOXO’s mission to revolutionize autonomous driving for Europe’s commercial fleets.
heyPatient, a Serpentine Ventures portfolio company, was featured on NextIn Business on SAT.1, showing its potential to save costs with digital automation. heyPatient streamlines healthcare for patients, staff, and the Swiss health system.